A study published in BMC Infectious Diseases has found that older patients with sepsis have lower 28-day mortality when blood ...

We suggest against using IV hydrocortisone to treat septic shock patients if adequate fluid resuscitation and vasopressor therapy are able to restore hemodynamic stability. If this is not achievable, ...

Findings from a MIMIC-IV database analysis challenge standard sepsis guidelines by suggesting moderately higher BP targets for patients aged 75 years or older.

A reduction in hospital mortality from severe sepsis and septic shock was associated with participation in the Surviving Sepsis Campaign performance improvement initiative. The researchers found the ...

With more than 1 million American dying from sepsis annually, providers follow a set of protocols to mitigate a patient’s risk of sepsis. JAMA delves into the updated guidelines, titled Surviving ...

Sepsis, a leading cause of death worldwide, demands a shift from generalized treatment to personalized, predictive, and technology-enabled strategies to improve outcomes globally Sepsis is a ...

Vasopressin caught fire as an adjunct vasopressor for sepsis about 20 years ago. The rationale was that septic patients are vasopressin deficient, at least relatively, and they require exogenous ...

Sepsis is a deadly reaction to infection, one that can cause runaway inflammation and a cascade of organ damage. It is estimated to kill at least 350,000 Americans per year. Early detection of this ...

Prolonged infusion of beta-lactam antibiotics for sepsis or septic shock tended to improve mortality compared with conventional intermittent infusion in the BLING III trial, and a meta-analysis ...

Kenneth E. Remy, MD, MHSc, MSCI, FCCM, The Ellery Sedgwick, Jr. Chair and Distinguished Scientist in Cardiovascular Research, Inaugural director of the Blood, Heart, Lung, and Immunology Research ...